Skip to content
★ Sign in to follow
DW

Dan W. Lufkin

STRATA Skin Sciences, Inc.
Total declarations
51
Company
1
▲ Purchases (42 ops.)
€1.3M
▼ Sales (0 ops.)
—

Latest filing published 19 Aug 2010 for STRATA Skin Sciences, Inc., €47k.

Insider track record

Disclosed buys
42
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
42
Positive at T+90
26%
Median T+90
-1.4%

Based on 35 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Dan W. Lufkin: trading record in brief

All filings by Dan W. Lufkin on record concern STRATA Skin Sciences, Inc. In total, 51 filings cover trades dated from 28 October 2005 to 19 August 2010.

On the market, this insider has only ever bought: 42 purchases, €1.3M in total. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants and 5 option exercises. 2010 to date brings 15 purchases and no sales.

Half of the purchases are above €4,230 and half below. Looking at 35 purchases old enough to measure, the stock rose over the following 90 days in 26% of cases; the median change was -1.4%. This is a record of the past, not a forecast.

Most recently, on 19 August 2010, the filings show an open-market purchase worth €47k in STRATA Skin Sciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Dan W. Lufkin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations42 total

25 of 42 declarations